Fitness barriers to spread of colistin resistance overcome by first establishing niche in patients with enhanced colistin exposure
Authors:
Preprint
Abstract
There is an urgent need to improve our understanding of how new antibiotic resistant organisms emerge and spread. A high-priority resistance threat is the ST258 lineage of carbapenem-resistant Klebsiella pneumoniae . Here, we studied resistance to the last-line drug colistin among ST258 by tracking its evolution across 21 U.S. hospitals over the course of a year. Phylogenetic analysis supported a significant fitness cost being associated with resistance, as resistance emergence was common but resistance variants were rarely transmitted. Furthermore, several resistance variants that were transmitted had acquired secondary variants that reverted the strain to susceptible. The exceptions to the general pattern of instability associated with resistance were two large clusters of resistant strains in one sublineage (clade IIB) present across Southern California hospitals. Quantification of transmission fitness in the healthcare environment indicated that, while resistant isolates from other clades were less fit than their susceptible counterparts, clade IIB resistant isolates were more fit, despite having similar resistance variants. Additional analyses supported the increased fitness of colistin-resistant clade IIB isolates being driven by a lineage-defining variant that increased clade IIB’s association with patient subpopulations with enhanced colistin exposure. These results show that a favorable genetic background and sustained selective pressure led to the emergence and spread of a colistin-resistant ST258 sublineage across a regional healthcare network. These findings highlight the utility of integrating pathogen genomic and corresponding clinical data from regional healthcare networks to detect emerging antibiotic resistance threats and understand the clinical practices and patient populations that drive their spread. Significance Statement: Selective pressure in hospitals leads to frequent antibiotic resistance evolution. However, emergent resistance alleles are often not transmitted to other individuals because of fitness costs associated with resistance. Due to the difficulty of studying pathogen fitness in humans, our understanding of how resistant organisms circumvent these costs is limited. We integrate genomic and clinical data to understand the evolutionary trajectories leading to transmissible resistance for the last-line antibiotic colistin. While colistin resistance is generally associated with a fitness cost that hinders transmission, this cost was mitigated in a sublineage that had previously acquired mutations increasing its association with patient populations more likely to receive colistin, suggesting a key role for historical contingency in the emergence and spread of stable resistance.Keywords
This publication has 52 references indexed in Scilit:
- In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin TreatmentAntimicrobial Agents and Chemotherapy, 2014
- Trimmomatic: a flexible trimmer for Illumina sequence dataBioinformatics, 2014
- Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatmentGenome Research, 2013
- Understanding, predicting and manipulating the genotypic evolution of antibiotic resistanceNature Reviews Genetics, 2013
- Ultrafast Approximation for Phylogenetic BootstrapMolecular Biology and Evolution, 2013
- Experimental evolutionTrends in Ecology & Evolution, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- The cost of antibiotic resistance from a bacterial perspectiveDrug Resistance Updates, 2000